Uncertainty Surrounds Novavax's COVID Vaccine Approval: Key Insights
In this video, we dive into the latest developments surrounding Novavax's COVID vaccine approval. After receiving emergency use authorization in August 2022, the path to full approval has faced significant hurdles. We discuss the FDA's missed April 1 deadline, the political factors at play, and the unique aspects of Novavax's protein-based ...
